Lv4
460 积分 2022-11-24 加入
Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a multicentre, double-blind, randomised, controlled, phase 3 trial
1天前
已完结
Impact of SGLT2 inhibitors on the outcomes of patients with cardiac arrhythmias and transthyretin cardiac amyloidosis
12天前
已关闭
Can SGLT2 Inhibitors ERASe Arrhythmias?
12天前
已完结
The Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Atrial Fibrillation Burden in Diabetic Patients
12天前
已完结
Comparison of Sodium–Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide Receptor Agonists for Atrial Fibrillation in Type 2 Diabetes Mellitus: Systematic Review With Network Meta-analysis of Randomized Controlled Trials
12天前
已完结
Efficacy of sodium-glucose cotransporter 2 inhibitors on preventing atrial arrhythmia recurrences after atrial fibrillation ablation in patients with heart failure
12天前
已完结
SGLT2 inhibitors: A potential therapeutic strategy for atrial fibrillation in pulmonary arterial hypertension-induced right heart failure?
12天前
已关闭
Cardiovascular outcomes with SGLT-2 inhibitors in individuals with diabetes and co-existing atrial fibrillation: A systematic review and meta-analysis
12天前
已完结
SGLT2 Inhibitors in atrial fibrillation: Ready for prime time?
12天前
已关闭
Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists
12天前
已完结
皖公网安备34019202002308
